Chemotherapy is essential for many cancer patients, but some suffer from cognitive impairment throughout treatment. "Chemobrain" can consist of deficits in memory, attention, and executive function.
Oct 19, 2023
0
66
For more than 25 years, Richard Huganir, Ph.D., Bloomberg Distinguished Professor of Neuroscience and Psychological and Brain Sciences and director of the Solomon H. Snyder Department of Neuroscience, at the Johns Hopkins ...
Oct 13, 2023
0
75
People with early Alzheimer's disease have difficulty turning when walking, according to a new study using virtual reality led by UCL researchers.
Oct 11, 2023
0
23
Western Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope in the treatment of mild cognitive impairment (MCI) among older people. The trial's results, ...
Oct 11, 2023
0
22
Alzheimer's disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the disease.
Sep 28, 2023
0
22
Long COVID patients have clear differences in immune and hormone function to patients without the condition, according to a new study led by the Icahn School of Medicine at Mount Sinai and Yale School of Medicine.
Sep 25, 2023
0
80
A third of people hospitalized with COVID-19 have "abnormalities" in multiple organs months after getting infected, a UK study said on Saturday, potentially shedding light on the elusive condition of long COVID.
Sep 23, 2023
0
106
Working consistently in an occupation with medium or high occupational physical activity was linked to an increased risk of cognitive impairment, according to a new study by the Norwegian National Centre of Ageing and Health ...
Sep 14, 2023
1
39
While advance directives are quite common for patients with physical impairments, advance directives for people with mental impairments are controversial. In many countries, including Germany, there are as yet no legal provisions ...
Sep 13, 2023
0
18
A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest ...
Aug 31, 2023
0
31
